InMed Pharmaceuticals (INM) Other Operating Expenses (2019 - 2026)

InMed Pharmaceuticals' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $74875.0 for Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 1.36% year-over-year to $74875.0 in Q1 2026; TTM through Mar 2026 was $252549.0, a 5.34% decrease from a year earlier, with the FY2025 full-year figure at $241310.0, up 20.05% from the prior year.
• Other Operating Expenses rose to $74875.0 in Q1 2026 per INM's latest filing, from $35065.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $3.5 million in Q2 2022 and bottomed at -$2.9 million in Q2 2023.
• The 5-year median for Other Operating Expenses is $74875.0 (2026), against an average of $188996.6.
• Biggest YoY gain for Other Operating Expenses was 1552.36% in 2023; the steepest drop was 182.37% in 2023.
• Year by year, Other Operating Expenses stood at $809530.0 in 2022, then slumped by 101.83% to -$14798.0 in 2023, then soared by 782.22% to $100955.0 in 2024, then sank by 65.27% to $35065.0 in 2025, then jumped by 113.53% to $74875.0 in 2026.
• Per Business Quant, the three latest INM Other Operating Expenses figures stand at $74875.0 (Q1 2026), $35065.0 (Q4 2025), and $110196.0 (Q3 2025).